Your institution may have access to this item. Find your institution then sign in to continue.
Title
Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.
Authors
Hooper, M J; Ebeling, P R; Roberts, A P; Graham, J J; Nicholson, G C; D'Emden, M; Ernst, T F; Wenderoth, D
Abstract
To assess the efficacy and tolerability of risedronate, a pyridinyl bisphosphonate, in preventing loss of bone mineral density (BMD) of the lumbar spine and proximal femur in early postmenopausal women.
Publication
Climacteric : the journal of the International Menopause Society, 2005, Vol 8, Issue 3, p251